Researchers

  • Alejandra Marín Arguedas

    Pneumology

  • Alex Roger Reig

    Pneumology

    Phd
  • Carme Santiveri Gilabert

    Pneumology

  • Concepción Cañete Ramos

    Pneumology

  • Elena Marcos

    Pneumology

  • Elena Miguel Campos

    Pneumology

  • Josefina Sabria

    Pneumology

    Phd
  • Lydia Luque Chacon

    Pneumology

  • Mª Victoria González

    Pneumology

  • Rose Blavia Aloy

    Pneumology

  • Rosa Montoliu Tarramera

    Pneumology

Contact the group

Form
  • Battista Migliori G, Min Thong P, Akkerman O, Alffenaar JW, Álvarez-Navascués F, Assao-Neino MM, Bernard PV, Biala JS, Blanc FX, Bogorodskaya EM, Borisov S, Buonsenso D, Calnan M, Castellotti PF, Centis R , Chakaya JM, Cho JG, Codecasa LF, D'Ambrosio L, Denholm J, Enwerem M, Ferrarese M, Galvão T, García-Clemente M, García-García JM, Gualano G, Gullón-Blanco JA, Inwentarz S, Ippolito G , Kunst H, Maryandyshev A, Melazzini M, Queiroz Mello FCD, Muñoz-Torrico M, Bung Njungfiyini P, Palmero DJ, Palmieri F, Piccioni P, Piubello A, Rendon A, Sabriá J, Saporiti M, Scognamiglio P, Sharma S, Silva DR, Souleymane MB, Spanevello A, Tabernero E, Tadolini M, Tchangou ME, Yatta Thornton AB, Tiberi S, Udwadia ZF, Sotgiu G, Min Ong CW, and Goletti D. 327/20

    Worldwide Effects of the Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020.

    Emerg Infect Dis. 2020 Nov;26(11):2709-2712
  • Coppola M, Villar-Hernández R, van Meijgaarden KE, Latorre I, Muriel Moreno B, Garcia-Garcia E, Franken KLMC, Prat C, Stojanovic Z, De Souza Galvão ML, Millet JP, Sabriá J, Sánchez-Montalva A, Noguera -Julian A, Geluk A, Domínguez J, Ottenhoff THM. 211/20

    Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups.

    Front Immunol. 2020 Feb 11;11:103.
  • Villar-Hernández R, Blauenfeldt T, García-García E, Muriel-Moreno B, De Souza-Galvão ML, Millet JP, Sabriá F, Sánchez-Montalvá A, Ruiz-Manzano J, Pilarte J, Jiménez MA, Centeno C, Martos C, Molina-Pinargote I, González-Díaz YD, Santiago J, Cantos A, Casas I, Guerola RM, Prat C, Andersen P, Latorre I, Ruhwald M, Domínguez J. 219/20

    Diagnostic benefits of adding EspC, EspF and Rv2348-B to the QuantiFERON Gold In-tube antigen combination.

    Sci Rep. 2020 Aug 6;10(1):13234.
  • Izquierdo-Garcia JL, Comella-Del-Barrio P, Campos-Olivas R, Villar-Hernández R, Prat-Aymerich C, De Souza-Galvão ML, Jiménez-Fuentes MA, Ruiz-Manzano J, Stojanovic Z, González A, Serra -Vidal M, García-García E, Muriel-Moreno B, Millet JP, Molina-Pinargote I, Casas X, Santiago J, Sabriá F, Martos C, Herzmann C, Ruiz-Cabello J, Domínguez J 220/20

    Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker.

    Sci Rep. 2020 Dec 18;10(1):22317.
  • Latorre I, Muriel-Moreno B, Fernández-Sanmartín MA, Vila S, Villar-Hernández R, De Souza-Galvao ML, Stojanovic Z, Jiménez-Fuentes MA, Centeno C, Ruiz-Manzano J, Millet JP, Molina-Pinargote I , González-Díaz YD, Luque-Chacón L, Sabriá J, Prat C, Domínguez J 122/19

    Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management.

    Front Immunol. 2019;9:3094.
  • Latorre I, Fernández-Sanmartín MA, Muriel-Moreno B, Villar-Hernández R, Vila S, De Souza-Galvão ML, Stojanovic Z, Jiménez-Fuentes MA, Centeno C, Ruiz-Manzano J, Millet JP, Molina-Pinargote I , González-Díaz Y, Lacoma A, Luque-Chancón L, Sabriá J, Prat C and Domínguez J. 24/18

    Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management.

    Front Immunol. 2018; 9: 3094.
  • Santin M, Barrabeig I, Malchair P, Gonzalez-Luquero L, Benitez MA, Sabria J, Palau-Benavent M, Cañete C, Lloret-Queraltó JA, Grijota-Camino MD, Dorca J, and Alcaide F. 25/18

    Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994–2014.

    Emerg Infect Dis. 2018;24(6):1091–1094.
  • Calle Rubio M, López-Campos JL, Soler-Cataluña JJ, Alcázar Navarrete B, Soriano JB, Rodríguez González-Moro JM, Fuentes Ferrer ME, Rodríguez Hermosa JL; EPOCONSUL Study. (From Miguel E). 1405

    Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study.

    Breath Nothing. 2017;18(1):200.
  • Lara B, Martínez-Delgado B, Torres ML, Marín-Arguedas S, Bustamante A, Miravitlles M. 1177

    Alpha-1-antitrypsin deficiency associated with the Mattawa variant.

    Arch Bronconeumol. 2013;49(12):548-50.
  • Roger A, Vázquez R, Almonacid C, Padilla A, Serrano J, García-Salmones M, Molina F, Pinedo C, Torrejón M, Picado C, López-Viña A, Plaza V; Asthma Emergent Group. SEPAR Asthma Area. 1126

    Knowledge of their own allergic sensitizations in asthmatic patients and its impact on the level of asthma control.

    Arch Bronconeumol. 2013;49(7):289-96.

Projects

  • Pneumology

    Researcher
    • Year 2020
    • HSDMB

    Association between vitamin D deficiency and tuberculosis in Spain.

    • DISTRICT ATTORNEY:

      Dr. Lydia Luque Chacon

    • TYPE E:

      PI

  • Pneumology

    Researcher
    • Year 2020
    • HDM

    Registry of the Spanish Society of Pulmonology and Thoracic Surgery of patients with COVID-19 (RECOVID).

    • DISTRICT ATTORNEY:

      Spanish Society of Pulmonology and Thoracic Surgery

    • TYPE E:

      EPA-OD

    • Year 2020
    • HSDMB

    Association between vitamin D deficiency and tuberculosis in Spain.

    • DISTRICT ATTORNEY:

      Dr. Lydia Luque Chacon

    • TYPE E:

      PINE TREE

    • Year 2020
    • HDM

    Registry of the Spanish Society of Pulmonology and Thoracic Surgery of patients with COVID-19 (RECOVID).

    • DISTRICT ATTORNEY:

      Spanish Society of Pulmonology and Thoracic Surgery

    • TYPE E:

      EPA-OD

  • Pneumology

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Study of the reversals of an interferon-γ release test (QuantiFERON-TB Gold Plus) for the optimization of the study of tuberculosis contacts.

    • DISTRICT ATTORNEY:

      Dr. Miguel Santin Cerezales from the Bellvitge University Hospital

    • TYPE E:

      PI

  • Pneumology

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Infections by non-tuberculous mycobacteria (NTM) in Spain: Epidemiological, microbiological and pathogenic clinical study.

    • DISTRICT ATTORNEY:

      Dr. Fernando Alcaide Fernández De Vega of the Microbiology Service of the Bellvitge University Hospital

    • TYPE E:

      EPA-AS

  • Pneumology

    Researcher
    • Year 2019
    • Comprehensive Care Center Dos de Maig Hospital

    Efficacy and safety of inhaled antibiotic therapy in patients with COPD and chronic bronchial infection.

    • DISTRICT ATTORNEY:

      COPD and Bronchiectasis PII of the SEPAR (Spanish Society of Pulmonology and Thoracic Surgery)

    • TYPE E:

      EPA-OD

  • Pneumology

    Researcher
    • Year 2019
    • Comprehensive Care Center Dos de Maig Hospital

    Knowledge of the correct use of inhalers by hospital nursing staff in a Second Level Hospital and the impact of a training intervention.

    • DISTRICT ATTORNEY:

      Alejandra Marin

    • TYPE E:

      PI

    • Year 2019
    • Comprehensive Care Center Dos de Maig Hospital

    Knowledge of the correct use of inhalers by hospital nursing staff in a Second Level Hospital and the impact of a training intervention.

    • DISTRICT ATTORNEY:

      Alejandra Marin

    • TYPE E:

      PINE TREE

    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Study of the reversals of an interferon-γ release test (QuantiFERON-TB Gold Plus) for the optimization of the study of tuberculosis contacts.

    • DISTRICT ATTORNEY:

      Dr. Miguel Santin Cerezales from the Bellvitge University Hospital

    • TYPE E:

      PINE TREE

Lines of action

  • COPD: Cognitive impairment, quality of life and nutritional status
  • bronchial asthma
  • Obesity and lung function
  • Obstruction of the upper airway secondary to goiter
  • Hypersensitivity pneumonitis, interstitial lung disease
  • Pulmonary tuberculosis and other communicable diseases of the respiratory system

Documents

Information of interest

Links